To determine whether the nongenomic actions of E2 have any beneficial effect on cardiac function following traumahemorrhage and whether those effects are mediated via the PI3K/ Akt pathway. Summary Background Data: Since studies suggest that both genomic and nongenomic pathways are involved in mediating the salutary effects of 17␤-estradiol (estradiol) following trauma-hemorrhage, we examined if the nongenomic effects of estradiol on cardiac function after trauma-hemorrhage involve the PI3K/Akt pathway. Methods: Male Sprague-Dawley rats (ϳ300 g) underwent traumahemorrhage (mean blood pressure, 40 mm Hg for 90 min, then resuscitation). Estradiol conjugated to bovine serum albumin (BSA) (estradiol-BSA; 1 mg/kg estradiol) with or without estrogen receptor antagonist (ICI 182,780), PI3K inhibitor (Wortmannin), or vehicle was injected intravenously during resuscitation. At 2 hours after trauma-hemorrhage or sham operation, cardiac output, stroke volume, heart rate, mean arterial pressure, and ϮdP/dt were measured. Cardiomyocyte PI3K, p-Akt, Akt protein expressions and apoptosis were also determined. One-way ANOVA and Tukey's test were used for statistical analysis. Results: Cardiac output, stroke volume, and ϮdP/dt decreased significantly after trauma-hemorrhage. Administration of estradiol or estradiol-BSA significantly improved these parameters of cardiac function. Although trauma-hemorrhage decreased cardiomyocyte PI3K protein expression and Akt phosphorylation (p-Akt), estradiol or estradiol-BSA treatment following trauma-hemorrhage prevented such decreases in cardiomyocyte PI3K protein expressions and p-Akt. The increase in cardiomyocyte apoptosis was also prevented in rats receiving estradiol-BSA. Co-administration of ICI 182,780 or Wortmannin abolished beneficial effects of estradiol-BSA on cardiac functions following trauma-hemorrhage. Conclusion: The PI3K/Akt pathway plays a critical role in mediating the nongenomic salutary effects of estradiol on cardiac function following trauma-hemorrhage. (Ann Surg 2007;245: 971-977) 
S tudies have suggested that male sex steroids are responsible for producing the depression in cell/organ functions following trauma-hemorrhage. 1 Support for this notion comes from studies showing that castration of male animals 14 days before trauma-hemorrhage prevented depression in myocardial functions. 1 Furthermore, administration of flutamide, a testosterone receptor antagonist, following trauma-hemorrhage in intact males also restored cardiac functions. 2 In contrast, 17␤-estradiol (E2) the predominant female sex hormone, is shown to have cardioprotective effects following adverse circulatory conditions such as trauma-hemorrhage, even in male animals. 2, 3 Moreover, it appears that the biologic effects of E2 on cardiac function are receptor dependent, since simultaneous administration of ICI 182,780, a selective estrogen receptor (ER) antagonist, abolished the salutary effects of E2 on cardiac function. 2, 4 The classic ER functions as a ligand-dependent transcription factor. However, recent studies have also provided information indicating that the signal transduction via ERs does not involve transcriptional gene regulation. 5, 6 Furthermore, there is growing evidence that ER can also mediate signaling cascades at the cell membrane and in the cytoplasm. 5, 7, 8 In the heart and vasculature, these nongenomic signaling pathways mediate rapid vasodilatation, 9 inhibition of the response to vessel injury, 10 reduction in myocardial injury after infarction, 11 and attenuation of cardiac hypertrophy. 12 The nongenomic effects of estrogen are thought to be mediated by receptors located in or close to the plasma membrane. [13] [14] [15] [16] To exclude the influence of genomic events mediated by the nuclear ERs, the membrane impermeable conjugates of E2, such as E2 conjugated to BSA (E2-BSA) 17 has been used. Several lines of evidence indicate that E2-BSA acts only on membrane ERs. First, by using a fluores-cent form, E2-BSA-FITC (E2-BSA conjugated to FITC), E2-BSA has been shown with confocal 18 and regular microscopy 19 to bind only to the plasma membrane, even after a prolonged (40 minutes) incubation that far exceeded the application time sufficient for achieving rapid E2 actions. 8 Second, this membrane binding is due specifically to E2 because BSA-FITC devoid of E2 does not bind to the plasma membrane. 18 Third, E2 binds to membrane ERs because 1) no binding was observed in cells devoid of ERs 19 ; and 2) the binding of E2-BSA-FITC to plasma membrane was blocked by ER antagonist ICI 182,780. 19 There is, however, evidence that E2-BSA does not bind to classic ER. 17 Finally, E2-BSA does not always act like E2, 20 indicating that direct E2/ER functions have been excluded.
Genomic action of estrogen is mediated by nuclear ERs and involves transcription; however, nongenomic action of estrogen is mediated by membrane ERs and does not require transcription. 8, 21 Nongenomic activation of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling cascade by E2 has been observed in multiple cell types. 22, 23 Furthermore, studies have shown that activation of PI3K pathway protects organs or cells against ischemia-reperfusion injury and hypoxia through suppression of the cell death machinery. 24 One of the downstream targets of PI3K pathway is the serine/threonine ͓kinase͔ Akt. 5, 23, 25 Previous studies suggested that an increase in Akt activity improved left ventricle contractile recovery following transient ischemia. 26 Thus, we hypothesized that nongenomic effects of E2 may attenuate cardiac injury through PI3K/Akt pathway. The aim of our study therefore was to determine whether the nongenomic actions of E2 have any beneficial effect on cardiac function following trauma-hemorrhage and whether those effects are mediated via PI3K/Akt pathway.
METHODS

Trauma-Hemorrhage Procedure
Male Sprague-Dawley rats (275-325 g; Charles River Labs, Wilmington, MA) were housed in an air-conditioned room under a reversed light-dark cycle for at least 1 week to adapt them to the environment. Prior to the experiment, they were fasted overnight but were allowed water ad libitum. The rats were anesthetized by isoflurane (Attane, Minrad Inc., Bethlehem, PA) inhalation prior to induction of soft tissue trauma via 5-cm midline laparotomy. 27 The abdomen was closed in layers, and catheters were placed in both femoral arteries and the right femoral vein (polyethylene ͓PE-50͔ tubing; Becton Dickinson & Co., Sparks, MD). The wounds were bathed with 1% lidocaine (Elkins-Sinn Inc., Cherry Hill, NJ) throughout the surgical procedure to reduce postoperative pain. Rats were then allowed to awaken, bled to and maintained at a mean arterial pressure of 40 mm Hg, maintained at that mean arterial pressure until 40% of the shed blood volume was returned in the form of Ringer's lactate, and were then resuscitated with 4 times the volume of shed blood over 60 minutes with Ringer's lactate. Thirty minutes before the end of resuscitation, rats received 17␤-estradiol (E2; 1 mg/kg, intravenously), E2 conjugated to BSA (E2-BSA, 1 mg/kg E2) with or without ER antagonist ICI 182,780 (3 mg/kg, intra-peritoneally at the beginning of resuscitation), PI3K inhibitor Wortmannin (16 g/kg, intravenously at the beginning of resuscitation), or an equal volume of vehicle. 6,28 E2-BSA was dissolved in phosphate buffer (pH 8.0) and filtered after a procedure proven to remove free E2. 17 The catheters were then removed, the vessels ligated, and the skin incisions closed with sutures. Sham-operated animals underwent the surgical procedure, which included a midline laparotomy in addition to the ligation of the femoral artery and vein, but neither hemorrhage nor resuscitation was carried out. The rats were then returned to their cages and were allowed food/ water ad libitum. All animal experiments were performed according to the guidelines of the Animal Welfare Act and the Guide for Care and Use of Laboratory Animals from the National Institutes of Health. This project was approved by the Institutional Animal Care and Use Committee of the University of Alabama at Birmingham.
Measurement of Cardiac Output and In Vivo Heart Performance
At 2 hours after the completion of fluid resuscitation, the animals were reanesthetized with pentobarbital sodium (25-30 mg/kg, intraperitoneally) and cardiac output and stroke volume were measured using a 2.4-Fr fiberoptic catheter and an in vivo hemoreflectometer (Hospex Fiberoptics, Chestnut Hill, MA), as described previously. 27 Our previous studies have shown that this level of anesthesia kept the animals anesthetized without having any significant negative effects on cardiac function. 29 Following the measurement of CO, the right carotid artery was recannulated with PE-50 tubing and connected to a blood pressure analyzer (DigiMed, Louisville, KY). After the mean blood pressure was recorded, the PE-50 tubing was advanced into the left ventricle and connected to a heart performance analyzer (DigiMed) to monitor and record maximal rate of pressure increase (ϩdP/dt max ) and decrease (ϪdP/dt max ), respectively. 27
Isolation of Cardiomyocytes
Immediately after the measurement of cardiac functions, heart was removed and retrograde aortic perfusion carried out at 37°C at a constant rate (12 mL/min/g tissue) for 5 minutes with a Ca 2ϩ -free Krebs buffer as described previously. 27 After perfusion, the ventricle was removed and cut into small chunks (ϳ1 ϫ 1 mm 3 ) and further digested with the buffer containing the digesting enzymes and 2% fat-free BSA in a shaker bath (60 -70 rpm) at 37°C at 5 g for 10 minutes. The supernatant containing cardiomyocytes was filtered through a 300-L filter into a 50-mL sterilized tube and gently centrifuged at 500 rpm for 1 minute. The pellets were reconstituted with ϳ30 mL BSA-free buffer (Ca 2ϩ -free Krebs buffer ϩ50 mmol/L CaCl 2 ), centrifuged at 500 rpm for 1 minute. The process of resuspension and centrifugation was repeated. Finally, the cardiomyocytes were resuspended in 0.02% Trypan blue and examined for viability.
Western Blot Assay
Rat cardiomyocytes were homogenized in a buffer as described previously. 27 The homogenates were centrifuged at 12,000g for 15 minutes at 4°C, analyzed using SDS-PAGE, and the proteins transferred to nitrocellulose membranes. The membranes were incubated with antibodies to total Akt protein, phospho (p)-Akt (Ser473) (Cell Signaling Technology, Inc., Beverly, MA), or antibodies to total PI3K protein (p85) (Upstate Biotechnology, Inc., Lake Placid, NY) overnight at 4°C. The membranes were incubated with horseradish peroxidase-conjugated goat anti-rabbit antibody or goat antimouse antibody for 1.5 hours at room temperature. After washing, blots were probed using enhanced chemiluminescence (Amersham, Piscataway, NJ) and then exposed to film. Signals were quantified using Cheminogen 5500 imaging software (Alpha Innotech Corp.).
Analysis of DNA Fragmentation by ELISA
Mono-and oligo-nucleosomes produced by endogenous endonucleases were detected using mouse monoclonal antibodies. The Cell Death Detection ELISA PLUS kit (Roche Diagnostics, Indianapolis, IN) was used to assess apoptosis, following manufacturer's directions. 7, 8 All samples were tested in duplicate, and the absorbance values were averaged. Results were calculated after subtracting the background value of the immunoassay from the average of the absorbance values.
Statistical Analysis
Results are presented as mean Ϯ SEM of 5 or 6 rats per group. The data were analyzed using one-way analysis of variance and Tukey's test, and differences were considered significant at P Յ 0.05.
RESULTS
Cardiac Functions
Trauma-hemorrhage produced a significant decrease in CO, SV, and ϮdP/dt max (Fig. 1 ). There was no significant difference in CO, SV, and ϮdP/dt max in shams receiving E2 or E2-BSA compared with vehicle-treated shams (data not shown). E2-BSA significantly improved CO and SV following trauma-hemorrhage; however, the values remained lower than shams and E2-treated trauma-hemorrhage rats (Fig. 1) . Moreover, E2-BSA prevented the decrease in ϩdP/dt max and ϪdP/dt max ; however, they also remained lower than shams and E2-treated trauma-hemorrhaged values (Fig. 1) . Administration of ER antagonist ICI 182,780 abolished the E2-BSA-induced improvement of cardiac function following trauma-hemorrhage.
Cardiomyocyte PI3K Protein Expression
There was a significant decrease in PI3K protein expression following trauma-hemorrhage (Fig. 2) ; E2 or E2-BSA treatment restored cardiomyocytes PI3K protein expression. However, coadministration of E2-BSA with ER antagonist ICI 182,780 prevented the E2-BSA-induced restoration of PI3K following trauma-hemorrhage.
Cardiomyocyte Akt Protein Expression and Activity
There was no significant difference in Akt protein expression between sham and trauma-hemorrhage rats (Fig. 3) . How-ever, the Akt activity as determined by its phosphorylation was significantly decreased following trauma-hemorrhage. Administration of E2 or E2-BSA following trauma-hemorrhage restored Akt activity to the levels observed in sham animals. The increase in p-Akt induced by E2 or E2-BSA was abolished by administration of ICI 182,780 ( Fig. 3) .
Since E2-BSA up-regulated cardiomyocytes PI3K following trauma-hemorrhage (Fig. 2) , we examined if administration of PI3K inhibitor Wortmannin had any effect on p-Akt. The result from this experiment suggest that coadministration of Wortmannin prevented the E2-BSA-induced restoration of cardiomyocytes p-Akt following trauma-hemorrhage ( Fig. 4 ). 
Cardiomyocyte DNA Fragmentation
Trauma-hemorrhage produced a significant increase in cardiomyocyte DNA fragmentation (Fig. 5 ), which was prevented following administration of E2-BSA. To evaluate whether the antiapoptotic effect of E2-BSA is via PI3K/Akt pathway, a group of trauma-hemorrhage rats was co-treated with E2-BSA and Wortmannin. Administration of Wortmannin abolished the E2-BSA-induced attenuation of cardiomyocyte DNA fragmentation following trauma-hemorrhage ( Fig. 5 ).
Effect of Wortmannin on Cardiac Functions
To determine the role of PI3K/Akt pathway in E2-BSA-induced cardioprotection following trauma-hemorrhage, rats were treated with the PI3K inhibitor Wortmannin along with E2-BSA. There was no significant difference in CO, SV, and ϮdP/dt max in shams receiving Wortmannin compared with vehicle-treated shams (data not shown). Furthermore, the results indicated that administration of Wortmannin with E2-BSA prevented the E2-BSA-induced cardioprotective effects in trauma-hemorrhage rats (Fig. 6 ). 
DISCUSSION
Given that the rapidity of activation makes modulation of gene transcription less likely and that the effects are not blocked by inhibitors of protein or RNA synthesis, these extranuclear mechanisms are commonly referred to as "nonnuclear" or "nongenomic" effects of E2. 21 In view of that, we attempted to determine whether E2's nongenomic effects play a role in cardioprotection following trauma-hemorrhage. Our results indicate that left ventricular performance (ϮdP/dt max ) was significantly depressed following trauma-hemorrhage. Male rats treated with E2-BSA displayed improvement in ϮdP/dt max at 2 hours following trauma-hemorrhage; moreover, the improved cardiac contractility was evident by the restored cardiac index. Furthermore, our findings indicate that the biologic effects of E2-BSA on cardiac function are receptor-dependent since the administration of ICI 182,780, a selective estrogen receptor antagonist, along with E2-BSA abolished the E2-BSAinduced cardioprotection in trauma-hemorrhage rats.
The present study is the first to examine the nongenomic effects of E2 on cardiac functions following traumahemorrhage and to show cardioprotective effects of E2-BSA in vivo. We used a cell-impermeable E2-BSA preparation to limit estrogen's actions to the cell membrane. It should be noted that, although E2 can dissociate from E2-BSA over time, the rate is very low (ϳ0.00063%/mL/h). 30 Based on this dissociation rate, the amount of free or unbound E2 in our model would be expected to be too low to stimulate even an extremely responsive E2 cell line, ie, MCF-7 cell line. 8 Other studies have also shown that E2-BSA does not activate estrogen receptor element-dependent transcription, again indicating that the compound remains extracellular. 31 Thus, it is safe to state that the actions of E2-BSA are membrane actions. Since such an effect occurs in the whole animal, it indicates that this type of hormonal potentiation is physiologically meaningful.
PI3K/Akt has been reported to play an important role in cell survival pathway. 6 Studies have also reported that PI3K/ Akt signal has an antiapoptotic activity through different mechanisms, eg, by phosphorylation of Akt, it induces BAD phosphorylation and hence inhibits its translocation into the mitochondria and binding to Bcl-2. 6 The mitochondrial permeability transition pore (PTP) is a latent nonspecific pore in the inner membrane of the mitochondria that has been widely recognized to play an important role during necrosis or apoptosis in many cell types. 6 Opening of PTP in stressful conditions leads to cell death, whereas inhibition of PTP prevents this pathologic insult thereby supporting the central role for PTP in cell survival. 32 Since free Bcl-2 is essential for maintaining the closed state of PTP, it is conceivable to consider that Akt phosphorylation inhibits the PTP. If PTP remains closed, cytochrome c is confined to the intramitochondrial space and hence unable to activate the proapoptotic caspases, including caspase 9. 33 These facts suggest that Akt activation is involved in cell survival. In our study, E2-BSA induced Akt phosphorylation and prevented DNA fragmentation in cardiomyocytes. These finding were further confirmed by using PI3K inhibitor Wortmannin that inhibited the E2-BSA-mediated protective effects on cardiomyocyte apoptosis and cardiac functions. It could be argued that we used ELISA method for measurement of DNA fragmentation for the analysis of cardiomyocyte apoptosis and that other methods, such as the Tunnel staining, should have been used. However, since ELISA is more specific and quantitative compared with Tunnel method, we chose ELISA method for analysis of cardiomyocyte DNA fragmentation.
Besides cardiomyocytes, we also found the reduction in p-Akt relative to total Akt in whole heart tissue and small intestine (data not shown). It is therefore tempting to postulate that administration of Wortmannin resulted in in vivo inhibition of PI3K. Previous studies have shown that Wort- Nongenomic Effects of Estrogen After Trauma-Hemorrhage mannin is a highly specific inhibitor of PI3K. 34 In addition to Wortmannin, LY294002 was also used as PI3K inhibitor in previous studies. 28 Stimulation of PI3K requires activation of the 85-kDa regulatory subunit, which relies on tyrosine phosphorylation, one consequence of which is activation of the 110-kDa catalytic subunit. Wortmannin, as well as LY294002, can block PI3K activity through direct interaction with the regulatory subunit (85 kDa) and the catalytic subunit (110 kDa) of PI3K. 34 Since Wortmannin has similar effects as LY294002, we used this agent to evaluate the role of PI3K in this study. Understanding the exact mechanism behind E2-BSAinduced Akt activation would be essential for understanding the nongenomic cardioprotective effects of E2-BSA following trauma-hemorrhage. We think that there might be 2 possible mechanisms behind the activation of Akt by E2-BSA. First, studies have demonstrated that activation of growth factors play an important role in PI3K pathway, which in turn activates Akt. It is therefore possible that E2-BSA treatment could activate certain growth factors. 17 Second, the E2 receptor has been shown to activate PI3K activity by association with the p85␣ regulatory subunit of PI3K in a ligand-dependent manner. 35 However, additional studies are required to clarify the exact mechanism of E2-BSA action on PI3K/Akt pathway.
It could be argued that the present study used measurement at 2 hours after treatment and thus it remains unclear whether the salutary effects of E2 or E2-BSA are sustained for longer periods of time. However, our previous studies have shown that if improvement in organ functions by any pharmacologic agent is evident at 2 hours after treatment, those salutary effects are sustained for prolonged intervals and those agents also improve the survival of animals. 2 Thus, although a time point other than 2 hours was not examined, based on our previous studies, it would appear that the salutary effects of E2 or E2-BSA on the measured parameters in different organs would be evident even if one measured those effects at another time point following trauma-hemorrhage and resuscitation. It can also be argued that Wortmannin should have been administered alone in sham groups to determine if each of those per se has any adverse effects. However, since our recent study has shown that administration of Wortmannin alone in sham-operated groups did not produce any deleterious effects (unpublished data), administration of Wortmannin alone was not carried out in this study.
